News Daily News DAPT De-escalation Success Varies by Sex: Meta-analysis Yael L. Maxwell August 21, 2025
News Daily News For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis Yael L. Maxwell August 14, 2025
News Daily News Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years Yael L. Maxwell June 09, 2025
News Daily News SCAD Story Fleshed Out by Clues About Causes, Treatment Risks Yael L. Maxwell March 13, 2025
News Daily News New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again Yael L. Maxwell November 27, 2024
News Daily News AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients Michael O'Riordan August 26, 2024
News Daily News P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed Yael L. Maxwell June 20, 2024
News Daily News Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2 Michael O'Riordan January 03, 2024
News Daily News Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis Yael L. Maxwell September 05, 2023
News Daily News Prehospital Cath Lab Activation in Australia Linked to Better STEMI Survival L.A. McKeown July 20, 2023
News Daily News P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI Yael L. Maxwell February 06, 2023
News Daily News STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden Caitlin E. Cox October 31, 2022
News Daily News New Biomarker-Based Risk Score Performs Well in ACS Michael O'Riordan October 25, 2022
News Daily News Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients L.A. McKeown June 29, 2022
News Daily News NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes L.A. McKeown May 03, 2022
News Daily News Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All L.A. McKeown April 05, 2021
News Daily News Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate L.A. McKeown February 26, 2021
News Daily News Site Investigators Missed Clinical Events in GLOBAL LEADERS Michael O'Riordan February 12, 2021